Date & Time
Monday, January 18, 2021, at 12.00 PM Brussels time
Join an expert panel to discuss lessons learnt on how to appropriately preserve elective surgeries during the COVID-19 pandemic. The COVID-19 pandemic has exposed vulnerabilities in healthcare systems across Europe and put extreme strain on hospitals. During the initial outbreak of SARS-CoV-2, European hospitals suspended elective surgeries and hospital treatments in hope of reducing infection rates and preserving resources for the treatment of COVID-19 patients. The postponement of surgeries and hospital treatments has resulted in a backlog of procedures with ongoing delays due to the overall diminished capacity of health systems. In the midst of the second wave, it is important to discuss the lessons learnt during the initial outbreak and assess the most effective strategies that can be applied to preserve elective surgeries. This EHMA webinar will discuss the lessons learnt from the pandemic from different country perspectives. What strategies can be adopted to ensure safety in all elective departments? How can resources be strategically allocated? What best practices can be shared and implemented across European countries.
Ernst Kuipers, Chairman of the Executive Board of the Erasmus Medical Center, The Netherlands
Ernst Kuipers trained in gastroenterology and hepatology. He was appointed as a member of the Executive Board on 1 December 2012 and has chaired the Board since 15 March 2013. He was educated in the Netherlands (in Groningen, Enschede, Deventer and Amsterdam) and, after obtaining his PhD, spent several years working in Nashville, USA.
He was appointed as a Professor of Gastroenterology and Hepatology and head of the Department of Gastroenterology and Hepatology in 2000, and in 2006 also became head of the Department of Internal Medicine. Among many other things, he was the driving force behind the launch of the national bowel cancer screening programme. The combination of his academic interests and his managerial experience in a wide range of international organisations and committees has given him a broad outlook on both national and international issues, as indeed he needs in order to perform his duties as chair of the Board.
Helen Pardoe, Chief Clinical Information Officer at The Princess Alexandra Hospitals NHS Trust, UK
She is Associate Medical Director for Quality Improvement at Princess Alexandra Hospital NHS trust and continues working as a consultant colorectal surgeon. She is clinical lead for the trust for Sepsis and Acute Kidney Injury and has recently set up the Lower GI Straight to test service for 2 WW in Harlow.
Before moving to PAH, she was consultant colorectal surgeon in East London for more than 13 years specialising in treating colorectal cancer, diverticular disease and benign anorectal conditions. She has been Lead Clinician for the colorectal MDT from 2006-2015, Clinical Director for Surgical Services 2008-2013 and was an active member of the Colorectal Pathway Board for the Integrated Cancer System London Cancer. She has a particular interest in the use of IT in improving access to health care and the use of digital technology to improve the recording of cancer data.
Giuseppe Banfi, Director of Scientific Research at Hospital Galeazzi, Milan, Italy
Dr Galeazzi is Director of Scientific Research programs at IRCCS, (Scientific and Teaching Hospital) Galeazzi Orthopaedic Institute and Director of Scientific Research programs at Gruppo Ospedaliero San Donato Foundation in Milan, Italy. From 2012, he is Member of Board of directors of Fondazione Istituto Insubrico Ricerca per La Vita Foundation. From 2006, he is also Associate Professor of Clinical Biochemistry and Clinical Molecular Biology at School of Medicine, University of Milano.
Aleksandra Krygiel-Nael, EMEA Acting Head of Government Affairs and Policy for Medical Devices
Aleksandra has experience in the area of pharmaceutical policy and has been cooperating with stakeholders and engaging on health innovation policy and value based healthcare on J&J behalf over the last four years. Before joining J&J in January 2017, Aleks worked with GSK vaccines in global access and public health. Aleks has also diverse communications consultancy background and started her career in the Polish embassy in Germany and the German Parliament. She has a legal background.
This webinar was financially supported by Johnson & Johnson.